Accelerated partner therapy: A promising new partner treatment option

Sexually Transmitted Infections

Volumn 88, Issue 1, 2012, Pages 2-3

  Dombrowski, Julia C ^a,b   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED PARTNER THERAPY; EDITORIAL; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE HOMOSEXUAL; PRIORITY JOURNAL; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; THERAPY;

COMMUNITY PHARMACY SERVICES; CONTACT TRACING; FEMALE; HOTLINES; HUMANS; MALE; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES;

EID: 84855866923     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050377     Document Type: Editorial

References (10)

1. Trelle S, Shang A, Nartey L, et al. Improved effectiveness of partner notification for patients with sexually transmitted infections: systematic review. BMJ 2007;334:354.
2. Pavlin NL, Parker RM, Piggin AK, et al. Better than nothing? Patient-delivered partner therapy and partner notification for chlamydia: the views of Australian general practitioners. BMC Infect Dis 2010;10:274.
3. Cameron ST, Glasier A, Muir A, et al. Expedited partner therapy for Chlamydia trachomatis at the community pharmacy. BJOG 2010;117:1074-9.
4. Jones HE, Lippman SA, Pinho AA, et al. Partner-delivered medication for sexually transmitted infections: findings from Brazil. Gac Med Mex 2006;142(Suppl 2):69-76.
5. Estcourt C, Sutcliffe L, Cassell J, et al. Can we improve partner notification rates through expedited partner therapy in the UK? Findings from an exploratory trial of accelerated partner therapy (APT). Sex Transm Infect 2012;88:21-6.
6. Roberts TE, Tsourapas A, Sutcliffe L, et al. Is Accelerated Partner Therapy (APT) a cost-effective alternative to routine patient referral partner notification in the UK? Preliminary cost-consequence analysis of an exploratory trial. Sex Transm Infect 2012;88:16-20.
7. Turner K, Adams E, Grant A, et al. Costs and cost effectiveness of different strategies for chlamydia screening and partner notification: an economic and mathematical modelling study. BMJ 2011;342:c7250.
8. Gift TL, Kissinger P, Mohammed H, et al. The cost and cost-effectiveness of expedited partner therapy compared with standard partner referral for the treatment of Chlamydia or gonorrhea. Sex Transm Dis 2011;38:1067-73.
9. Low N. Screening programmes for chlamydial infection: when will we ever learn? BMJ 2007;334:725-8. (Pubitemid 46623736)
10. Kerani RP, Fleming M, Deyoung B, et al. A randomized, controlled trial of inSPOT and patient-delivered partner therapy for gonorrhea and chlamydial infection among men who have sex with men. Sex Transm Dis 2011;38:941-6.